Rifater is a Oral Tablet, Sugar Coated in the Human Prescription Drug category. It is labeled and distributed by Sanofi-aventis U.s. Llc. The primary component is Rifampin; Isoniazid; Pyrazinamide.
| Product ID | 0088-0576_2209334f-337a-4dd3-82e4-64ffe1895ff3 |
| NDC | 0088-0576 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Rifater |
| Generic Name | Rifampin, Isoniazid And Pyrazinamide |
| Dosage Form | Tablet, Sugar Coated |
| Route of Administration | ORAL |
| Marketing Start Date | 1994-05-31 |
| Marketing Category | NDA / NDA |
| Application Number | NDA050705 |
| Labeler Name | sanofi-aventis U.S. LLC |
| Substance Name | RIFAMPIN; ISONIAZID; PYRAZINAMIDE |
| Active Ingredient Strength | 120 mg/1; mg/1; mg/1 |
| Pharm Classes | Rifamycin Antibacterial [EPC],Rifamycins [CS],Antimycobacterial [EPC],Antimycobacterial [EPC] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2021-12-31 |
| Marketing Start Date | 1994-05-31 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA050705 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 1994-05-31 |
| Ingredient | Strength |
|---|---|
| RIFAMPIN | 120 mg/1 |
| SPL SET ID: | 429a2f62-9fe6-4299-b314-92a9d22b1381 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() RIFATER 74146551 1866178 Live/Registered |
AVENTISUB LLC 1991-03-11 |
![]() RIFATER 73482128 1321748 Dead/Cancelled |
Merrell Dow Pharmaceuticals Inc. 1984-05-25 |